178 related articles for article (PubMed ID: 11004527)
21. Dipeptidyl peptidase expression during experimental colitis in mice.
Yazbeck R; Sulda ML; Howarth GS; Bleich A; Raber K; von Hörsten S; Holst JJ; Abbott CA
Inflamm Bowel Dis; 2010 Aug; 16(8):1340-51. PubMed ID: 20186930
[TBL] [Abstract][Full Text] [Related]
22. Prolyl peptidases related to dipeptidyl peptidase IV: potential of specific inhibitors in drug discovery.
Van der Veken P; Haemers A; Augustyns K
Curr Top Med Chem; 2007; 7(6):621-35. PubMed ID: 17352682
[TBL] [Abstract][Full Text] [Related]
23. Emerging family of proline-specific peptidases of Porphyromonas gingivalis: purification and characterization of serine dipeptidyl peptidase, a structural and functional homologue of mammalian prolyl dipeptidyl peptidase IV.
Banbula A; Bugno M; Goldstein J; Yen J; Nelson D; Travis J; Potempa J
Infect Immun; 2000 Mar; 68(3):1176-82. PubMed ID: 10678923
[TBL] [Abstract][Full Text] [Related]
24. Non-substrate peptides influencing dipeptidyl peptidase IV/CD26 activity and immune cell function.
Wrenger S; Faust J; Mrestani-Klaus C; Brandt W; Thielitz A; Neubert K; Reinhold D
Front Biosci; 2008 May; 13():3194-201. PubMed ID: 18508427
[TBL] [Abstract][Full Text] [Related]
25. Complementary action of dipeptidyl peptidase IV and aminopeptidase M in the digestion of beta-casein.
Heymann E; Mentlein R
J Dairy Res; 1986 May; 53(2):229-36. PubMed ID: 2873157
[TBL] [Abstract][Full Text] [Related]
26. A peptide-hormone-inactivating endopeptidase in Xenopus laevis skin secretion.
Carvalho KM; Joudiou C; Boussetta H; Leseney AM; Cohen P
Proc Natl Acad Sci U S A; 1992 Jan; 89(1):84-8. PubMed ID: 1729723
[TBL] [Abstract][Full Text] [Related]
27. Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase (QPP)/dipeptidyl peptidase 7 (DPP7).
Maes MB; Lambeir AM; Gilany K; Senten K; Van der Veken P; Leiting B; Augustyns K; Scharpé S; De Meester I
Biochem J; 2005 Mar; 386(Pt 2):315-24. PubMed ID: 15487984
[TBL] [Abstract][Full Text] [Related]
28. Purification and characterization of barley dipeptidyl peptidase IV.
Davy A; Thomsen KK; Juliano MA; Alves LC; Svendsen I; Simpson DJ
Plant Physiol; 2000 Feb; 122(2):425-32. PubMed ID: 10677435
[TBL] [Abstract][Full Text] [Related]
29. Characterisation of human dipeptidyl peptidase IV expressed in Pichia pastoris. A structural and mechanistic comparison between the recombinant human and the purified porcine enzyme.
Bär J; Weber A; Hoffmann T; Stork J; Wermann M; Wagner L; Aust S; Gerhartz B; Demuth HU
Biol Chem; 2003 Dec; 384(12):1553-63. PubMed ID: 14719797
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of human immunodeficiency virus type 1 infection in a T-cell line (CEM) by new dipeptidyl-peptidase IV (CD26) inhibitors.
Jiang JD; Wilk S; Li J; Zhang H; Bekesi JG
Res Virol; 1997; 148(4):255-66. PubMed ID: 9272576
[TBL] [Abstract][Full Text] [Related]
31. Molecular cloning and biochemical characterization of Xaa-Pro dipeptidyl-peptidase from Streptococcus mutans and its inhibition by anti-human DPP IV drugs.
De A; Lupidi G; Petrelli D; Vitali LA
FEMS Microbiol Lett; 2016 May; 363(9):. PubMed ID: 27010012
[TBL] [Abstract][Full Text] [Related]
32. Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN-like proteases in cerebral ischemia.
Röhnert P; Schmidt W; Emmerlich P; Goihl A; Wrenger S; Bank U; Nordhoff K; Täger M; Ansorge S; Reinhold D; Striggow F
J Neuroinflammation; 2012 Feb; 9():44. PubMed ID: 22373413
[TBL] [Abstract][Full Text] [Related]
33. Decisive structural determinants for the interaction of proline derivatives with the intestinal H+/peptide symporter.
Brandsch M; Knütter I; Thunecke F; Hartrodt B; Born I; Börner V; Hirche F; Fischer G; Neubert K
Eur J Biochem; 1999 Dec; 266(2):502-8. PubMed ID: 10561591
[TBL] [Abstract][Full Text] [Related]
34. Are diprotin A (Ile-Pro-Ile) and diprotin B (Val-Pro-Leu) inhibitors or substrates of dipeptidyl peptidase IV?
Rahfeld J; Schierhorn M; Hartrodt B; Neubert K; Heins J
Biochim Biophys Acta; 1991 Jan; 1076(2):314-6. PubMed ID: 1671823
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of dipeptidyl peptidase IV by fluoroolefin-containing N-peptidyl-O-hydroxylamine peptidomimetics.
Lin J; Toscano PJ; Welch JT
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14020-4. PubMed ID: 9826645
[TBL] [Abstract][Full Text] [Related]
36. Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites.
Lorey S; Stöckel-Maschek A; Faust J; Brandt W; Stiebitz B; Gorrell MD; Kähne T; Mrestani-Klaus C; Wrenger S; Reinhold D; Ansorge S; Neubert K
Eur J Biochem; 2003 May; 270(10):2147-56. PubMed ID: 12752434
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of dipeptidyl peptidase IV (DPP IV) by 2-(2-amino-1-fluoro-propylidene)-cyclopentanecarbonitrile, a fluoroolefin containing peptidomimetic.
Zhao K; Lim DS; Funaki T; Welch JT
Bioorg Med Chem; 2003 Jan; 11(2):207-15. PubMed ID: 12470715
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of dipeptidyl-peptidase IV catalyzed peptide truncation by Vildagliptin ((2S)-{[(3-hydroxyadamantan-1-yl)amino]acetyl}-pyrrolidine-2-carbonitrile).
Brandt I; Joossens J; Chen X; Maes MB; Scharpé S; De Meester I; Lambeir AM
Biochem Pharmacol; 2005 Jul; 70(1):134-43. PubMed ID: 15907807
[TBL] [Abstract][Full Text] [Related]
39. Prolyl oligopeptidase and dipeptidyl peptidase II/dipeptidyl peptidase IV ratio in the cerebrospinal fluid in Parkinson's disease: historical overview and future prospects.
Nagatsu T
J Neural Transm (Vienna); 2017 Jun; 124(6):739-744. PubMed ID: 27503084
[TBL] [Abstract][Full Text] [Related]
40. Similarities of the substrate cleavage catalyzed by proline specific endopeptidase and dipeptidyl peptidase IV.
Weidhase R; Welker P; Dove S; Neubert K; Yoshimoto T; Tsuru D; Barth A
Pharmazie; 1984 Dec; 39(12):835-7. PubMed ID: 6152335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
